nitroaspirin has been researched along with Hyperglycemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bolli, GB; Giannini, S; Gresele, P; Guglielmini, G; Lucidi, P; Marzotti, S; Minuz, P; Momi, S | 1 |
Del Soldato, P; Felix, CC; Olds, CL; Pieper, GM; Siebeneich, W | 1 |
1 trial(s) available for nitroaspirin and Hyperglycemia
Article | Year |
---|---|
Hyperglycemia-induced platelet activation in type 2 diabetes is resistant to aspirin but not to a nitric oxide-donating agent.
Topics: Adolescent; Adult; Aged; Aspirin; Female; Flow Cytometry; Humans; Hyperglycemia; Male; Middle Aged; Nitric Oxide Donors; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Young Adult | 2010 |
1 other study(ies) available for nitroaspirin and Hyperglycemia
Article | Year |
---|---|
Vascular protective actions of a nitric oxide aspirin analog in both in vitro and in vivo models of diabetes mellitus.
Topics: Acetylcholine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta, Thoracic; Aspirin; Diabetes Mellitus, Experimental; Electron Spin Resonance Spectroscopy; Electrophoretic Mobility Shift Assay; Endothelium, Vascular; Free Radical Scavengers; Gene Expression; Glucose; Hydroxyl Radical; Hyperglycemia; Isoprostanes; Muscle Relaxation; Muscle, Smooth, Vascular; NF-kappa B; Nitric Oxide; Norepinephrine; Rats; Rats, Sprague-Dawley; Superoxides; Vasodilation | 2002 |